The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
May 20th 2024
The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). (aflibercept). However, patent litigation has left it unclear when the biosimilars will come to market.
Improving Outcomes and Quality of Care in Age-Related Macular Degeneration and Diabetic Macular Edema: Patient-Centered Strategies in Managed Care
3.0 Credits / Ophthalmology/Optometry
View More
Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars
1.0 Credit / Ophthalmology/Optometry
View More
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
2.0 Credits / Ophthalmology
View More
Dr Robert Fante: More Data Will Provide More Insight Into Use of Teprotumumab for TED
March 7th 2022As more data are gathered on teprotumumab for use in thyroid eye disease (TED), we’ll have a better understanding of which subgroups respond better or worse to the treatment, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.
Watch
Addressing Patient Adherence in Glaucoma Management
Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.
Watch
Glaucoma: Utilization Management and Patient Access to Therapy
Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.
Watch
Dr James Auran Outlines How to Address Shortages of Ophthalmic Trauma Care Providers
February 18th 2022James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, lists potential solutions to bolster ophthalmic trauma care in the United States.
Watch
Xipere for Macular Edema Associated With Uveitis Launches in United States
February 16th 2022The treatment was approved in October 2021 and is the first FDA-approved therapy to treat macular edema associated with uveitis via injection to the suprachoroidal space, which provides a more targeted delivery mechanism.
Read More
The Importance of Vision Preservation in Patients With Glaucoma
A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.
Watch
Dr Anne Barmettler Discusses Potential Adverse Events Associated With Teprotumumab
February 7th 2022Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, outlines adverse events patients taking teprotumumab for thyroid eye disease may experience.
Watch
Dr Leon Herndon on Tailoring Glaucoma Care for Older Patients
February 3rd 2022Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.
Watch
AI-Based Anomaly Detection Holds Promise in Screening for Retinal Diseases, Study Says
January 17th 2022Recent findings suggest that with more research, anomaly detection may be an option for general retinal disease screening and identification of novel presentations of common retinal diseases.
Read More